SYRA

SYRA

USD

Syra Health Corp. Class A Common Stock

$0.090-0.005 (-5.258%)

Reaalajas hind

Healthcare
Medical Care Facilities
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$0.095

Kõrge

$0.095

Madal

$0.090

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.1M

Tööstusharu

Medical Care Facilities

Riik

United States

Kauplemisstatistika

Keskmine maht

1.01M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.031Praegune $0.090Kõrge $2.27

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 5. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

SYRA: Syra Health Corp. Class A Common Stock - What's Happening and What to Watch

Stock Symbol: SYRA Generate Date: 2025-05-05 00:20:25

Let's break down what's been going on with Syra Health's stock based on the latest information. We'll look at the news, how the price has moved, and what some automated predictions are saying.

The Latest Buzz: News Check

What's been hitting the news wires lately? Well, it's a bit of a mixed bag for Syra Health, but one piece of news is a really big deal.

Back in March, the company announced they snagged a nice contract extension worth $660,000 for their population health work. That sounds good, right? More business coming in is usually a positive sign for a company.

But then, just recently, on April 1st, came the other news: Syra Health is voluntarily delisting from the Nasdaq Capital Market. This is a significant move. When a company leaves a major exchange like Nasdaq, it often means they couldn't meet the listing requirements anymore, or they've decided to go private or trade on a less regulated market. For investors trading on Nasdaq, this is generally seen as a negative event. It can make the stock harder to buy and sell (less liquidity) and might signal underlying issues.

So, while getting a new contract is positive, the news about leaving Nasdaq is a much larger, and typically negative, development for a publicly traded stock.

Checking the Price Chart

Looking at the stock price itself over the last few months, things haven't been pretty. The price has been on a clear downward slide. Back in early February, shares were trading around $0.40 to $0.45. By the end of March, they had drifted down into the $0.20s.

Then came April 1st, the same day as the delisting announcement. The price took a sharp dive, falling significantly in the days that followed. It's been bouncing around at very low levels since then, often below $0.10. The recent price is a fraction of where it was just a couple of months ago.

An AI model is predicting small percentage increases for the next few days (around 1.9% to 2.8%). This suggests the model sees a potential tiny bounce from these extremely low levels in the very short term. However, the overall trend shown by the actual price history is strongly down, especially following that key news date.

Putting It All Together: What Might This Mean?

So, what's the picture when we combine the news and the price action?

The voluntary delisting from Nasdaq is the dominant factor here. The market's reaction, with the sharp price drop right after the announcement, confirms this is viewed negatively by investors trading on that exchange. While the contract extension is positive business news, it hasn't been enough to counter the impact of leaving Nasdaq.

Given the strong downtrend and the major negative news event (delisting), the situation for SYRA stock, particularly for those trading on Nasdaq, looks challenging. The AI's prediction of small short-term gains is interesting, but it's a tiny predicted move compared to the massive drop that has already occurred. The AI also mentions a much higher potential target price ($0.90), but this seems disconnected from the current reality of the price collapse and delisting.

The apparent near-term leaning, based on the news and price trend, is one of extreme caution. For investors focused on trading on major exchanges, the delisting event itself is often a signal to exit or avoid the stock due to reduced liquidity and visibility.

Potential Considerations (Use Extreme Caution):

  • For those already holding: The delisting significantly changes the investment landscape. If you're holding shares, you'll need to understand where they will trade next (likely over-the-counter) and the implications for liquidity. Setting a point where you'd get out if the price keeps falling – often called a stop-loss – makes sense to limit potential further losses, perhaps below the recent absolute lows (like $0.03 or $0.05), though volatility is very high at these levels.
  • For those considering buying: The delisting introduces significant risk and uncertainty. While the price is very low, and the AI sees potential for small short-term gains or a much larger move (though the latter seems questionable given the context), this is a highly speculative situation. The primary factor to consider is the impact of the delisting on future trading. Any potential entry would be highly risky and only for those comfortable with the implications of trading a delisted stock. The AI suggests potential entry points around $0.10 or $0.15, but the price has struggled to stay above these levels recently.

A Bit About the Company

Just to remember who we're talking about, Syra Health is a healthcare technology company. They work in areas like mental health, population health, and providing healthcare staff. The contract extension news fits right into their population health business. Keep in mind, this is a relatively small company (check the market cap) and the stock has shown extreme volatility, especially lately.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock trading involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions. The delisting of a stock has significant implications that should be fully understood before trading.

Seotud uudised

PR Newswire

Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market

Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through...

Vaata rohkem
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
PR Newswire

Syra Health Secures $660,000 Population Health Contract Extension

Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and...

Vaata rohkem
Syra Health Secures $660,000 Population Health Contract Extension

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 4. mai 2025, 19:42

LangevNeutraalneTõusev

72.0% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
Väärtus
Kauplemisjuhend

Sisenemispunkt

$0.10

Võta kasum

$0.16

Peata kahjum

$0.08

Põhitegurid

Praegune hind on 4.0% üle MA(20) taseme $0.09
DMI näitab langustrendi (ADX:24.0, +DI:47.6, -DI:48.4), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($0.09) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
MACD 0.0078 on signaalijoone 0.0036 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.